A detailed history of Carmel Capital Partners, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Carmel Capital Partners, LLC holds 13,784 shares of ILMN stock, worth $1.53 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
13,784
Previous 11,125 23.9%
Holding current value
$1.53 Million
Previous $1.45 Million 26.97%
% of portfolio
0.79%
Previous 0.59%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$128.99 - $155.15 $342,984 - $412,543
2,659 Added 23.9%
13,784 $1.84 Million
Q3 2024

Nov 01, 2024

SELL
$105.28 - $135.9 $440,175 - $568,197
-4,181 Reduced 27.32%
11,125 $1.45 Million
Q2 2024

Jul 31, 2024

BUY
$101.05 - $133.57 $178,656 - $236,151
1,768 Added 13.06%
15,306 $1.6 Million
Q1 2024

Apr 25, 2024

BUY
$127.73 - $147.2 $144,718 - $166,777
1,133 Added 9.13%
13,538 $1.86 Million
Q4 2023

Jan 31, 2024

BUY
$92.79 - $142.53 $543,656 - $835,083
5,859 Added 89.51%
12,405 $1.73 Million
Q3 2023

Oct 27, 2023

BUY
$128.91 - $192.44 $73,091 - $109,113
567 Added 9.48%
6,546 $898,000
Q2 2023

Jul 27, 2023

BUY
$183.43 - $232.67 $55,212 - $70,033
301 Added 5.3%
5,979 $1.12 Million
Q1 2023

Apr 19, 2023

SELL
$193.75 - $232.55 $104,043 - $124,879
-537 Reduced 8.64%
5,678 $1.32 Million
Q4 2022

Jan 17, 2023

SELL
$187.24 - $242.74 $444,882 - $576,750
-2,376 Reduced 27.66%
6,215 $0
Q3 2022

Oct 14, 2022

SELL
$177.23 - $227.44 $332,660 - $426,904
-1,877 Reduced 17.93%
8,591 $1.64 Million
Q2 2022

Jul 11, 2022

BUY
$181.58 - $368.0 $1.63 Million - $3.31 Million
9,000 Added 613.08%
10,468 $1.93 Million
Q1 2022

Apr 18, 2022

BUY
$303.87 - $423.8 $264,366 - $368,706
870 Added 145.48%
1,468 $513,000
Q4 2021

Jan 31, 2022

BUY
$347.28 - $421.83 $207,673 - $252,254
598 New
598 $228,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $17.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Carmel Capital Partners, LLC Portfolio

Follow Carmel Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmel Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carmel Capital Partners, LLC with notifications on news.